Post hoc analysis of the interventional management of stroke III trial, a multicenter phase 3 trial involving 900 subjects evaluating low-dose IV tPA plus thrombectomy or IV tPA alone (which was discontinued due to futility), demonstrated the importance of collateral circulation status for clinical outcomes. The gene discussed is PLAT; the disease is Stroke.